Laekna, Inc._Providing professional financial news and data related to Laekna, Inc., committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

Laekna, Inc.(02105.HK): Proposed Share Buyback Plus Senior Management Share Purchases Up to Aggregate HK$56 Million

Tags：

Laekna, Inc.02105.HK

2026-07-02

Finance
Insilico Medicine (03696.HK): Strategic Partnership with Takeda for AI-Driven Drug Discovery with Total Value Up to USD 600 Million
Finance
MANYCORE TECH (00068.HK): Grant of 1,130,000 Restricted Share Units to 24 Employees
Finance
People's Insurance Company of China Group (01339.HK): Appointment Qualification of Vice President Zhang Daoming Approved by the State Administration of Financial Regulation
Finance
Laekna, Inc.(02105.HK): Proposed Share Buyback Plus Senior Management Share Purchases Up to Aggregate HK$56 Million
Finance
SF Intra-city (09699.HK): Total 19.11 Million Shares Purchased under H-Share Incentive Scheme at Total Cost of Approximately HK$193 Million
Finance
Abbisko(02256.HK): Strategic Cooperation Reached with AstraZeneca to Advance Clinical Study of ABSK043 Combined with Tagrisso for NSCLC Treatment
Finance
Ribo Life Science(06938.HK): Milestone Achieved with Selection of First Candidate Drug under Collaboration with Madrigal
Finance
Ganfeng Lithium (01772.HK): Shareholder Wang Xiaoshen Pledges 5.7 Million Shares, Cumulative Pledge Ratio Accounts for 46.96% of His Shareholding
Finance
SSY Group Limited(02005.HK): Methocarbamol Tablets Approved for Marketing; Phloroglucinol API Granted Registration
Finance
Leads Biolabs(09887.HK): Grant of 2,254,691 H-share Awards to 149 Grantees

Scan QR Code

Download App